Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase II contract was awarded to Cellerant Therapeutics in January, 2018 for $1,117,159.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42AI108016-02A1 | Phase II | 1,117,159 | January 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Cellerant Therapeutics for $804,638.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI061856-01 | Phase I | 804,638 | ||||||||
A STTR Phase I contract was awarded to Cellerant Therapeutics for $300,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA126604-01 | Phase I | 300,000 | ||||||||
A SBIR Phase I contract was awarded to Cellerant Therapeutics for $194,467.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO120076 | Phase I | 194,467 | ||||||||
A SBIR Phase I contract was awarded to Cellerant Therapeutics for $296,883.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI064156-01 | Phase I | 296,883 | ||||||||
A SBIR Phase I contract was awarded to Cellerant Therapeutics for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HL073553-01 | Phase I | 100,000 | ||||||||
A SBIR Phase II contract was awarded to Cellerant Therapeutics for $2,045,700.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI064156-02 | Phase II | 2,045,700 | ||||||||
A STTR Phase I contract was awarded to Cellerant Therapeutics for $200,787.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI108016-01 | Phase I | 200,787 | ||||||||
A SBIR Phase I contract was awarded to Cellerant Therapeutics for $223,524.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CO140030 | Phase I | 223,524 | ||||||||
A SBIR Phase II contract was awarded to Cellerant Therapeutics for $1,496,276.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201600043C-0-0-0 | Phase II | 1,496,276 |